The risk of bone fractures in dementia patients receiving acetylcholinesterase inhibitors: a meta-analysis

CONCLUSION: Our study revealed no role for acetylcholinesterase inhibitors in increasing the risk of fracture compared with controls. Hence, based on our analysis, they might have a protective role against fracture when used for long periods considering their positive action on bone growth and development. Therefore, Acetylcholinesterase inhibitors could be considered a safe option for improving cognitive functions in elderly demented patients without carrying any additional risks.PMID:38576949 | PMC:PMC10990402 | DOI:10.1097/MS9.0000000000001721

Source: Annals of Medicine - April 5, 2024 Category: Internal Medicine Authors: Rowan H Elhalag Pens ée Chèbl Nervana M Bayoumy Noheir Ashraf Ibrahem Fathy Hassan Hanan Hagar Marwan Abowafia Hamed Gaber Mohamed Mohamed Belal Jaffer Shah Karam R Motawea Source Type: research